BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hahn GD, LeBlanc JF, Golovics PA, Wetwittayakhlang P, Qatomah A, Wang A, Boodaghians L, Liu Chen Kiow J, Al Ali M, Wild G, Afif W, Bitton A, Lakatos PL, Bessissow T. Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study. World J Gastroenterol 2022; 28(33): 4823-4833 [PMID: 36156919 DOI: 10.3748/wjg.v28.i33.4823]
URL: https://www.wjgnet.com/1007-9327/full/v28/i33/4823.htm
Number Citing Articles
1
Suja P. Davis, Rachel McInerney, Stephanie Fisher, Bethany Lynn Davis. Therapeutic Needs of Older Adults with Inflammatory Bowel Disease (IBD): A Systematic ReviewGastroenterology Insights 2024; 15(3): 835 doi: 10.3390/gastroent15030059
2
Federica Soardo, Andrea Spini, Giorgia Pellegrini, Giorgio Costa, Clément Mathieu, Chiara Bellitto, Luca L’Abbate, Ylenia Ingrasciotta, Olivia Leoni, Martina Zanforlini, Domenica Ancona, Paolo Stella, Anna Cavazzana, Angela Scapin, Sara Lopes, Valeria Belleudi, Stefano Ledda, Paolo Carta, Paola Rossi, Lucian Ejlli, Ester Sapigni, Aurora Puccini, Rita Francesca Scarpelli, Giovambattista De Sarro, Alessandra Allotta, Sebastiano Addario Pollina, Roberto Da Cas, Giampaolo Bucaneve, Antea Maria Pia Mangano, Francesco Balducci, Carla Sorrentino, Ilenia Senesi, Marco Tuccori, Rosa Gini, Stefania Spila-Alegiani, Marco Massari, Silvana Anna Maria Urru, Annalisa Campomori, Gianluca Trifirò. Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database NetworkBioDrugs 2025;  doi: 10.1007/s40259-025-00716-2
3
Walter Fries, Giorgio Basile, Federica Bellone, Giuseppe Costantino, Anna Viola. Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel DiseaseCells 2023; 12(13): 1722 doi: 10.3390/cells12131722
4
Gerum Gashaw Gebeyehu, Giacomo Broglio, Eleanor Liu, Jimmy K Limdi, Christian Selinger, Joseph Fiske, Violeta Razanskaite, Philip J Smith, Paul K Flanagan, Sreedhar Subramanian. Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn’s Disease PatientsInflammatory Bowel Diseases 2024;  doi: 10.1093/ibd/izae174
5
Yafang Li, Jin Ding, Chong Lu, Yiping Hong, Qunying Wang. Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta‑analysisActa Pharmaceutica 2025; 75(1): 23 doi: 10.2478/acph-2025-0004
6
Renata Talar-Wojnarowska, Miłosz Caban, Marta Jastrzębska, Małgorzata Woźniak, Aleksandra Strigáč, Ewa Małecka-Wojciesko. Inflammatory Bowel Diseases in the Elderly: A Focus on Disease Characteristics and Biological Therapy PatternsJournal of Clinical Medicine 2024; 13(10): 2767 doi: 10.3390/jcm13102767
7
Deloshaan Subhaharan, Pradeep Kakkadasam Ramaswamy, Laura Willmann, Hadi Moattar, Maneesha Bhullar, Naveed Ishaq, Alexander Dorrington, Dheeraj Shukla, Carolyn McIvor, John Edwards, Waled Mohsen. Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adultsWorld Journal of Gastroenterology 2023; 29(16): 2469-2478 doi: 10.3748/wjg.v29.i16.2469